Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
Published October 14, 2026 · Recall initiated: July 29, 2026
Summary
FDA records drug Class II recall D-0012-2027, published October 14, 2026 and initiated July 29, 2026. Recalling firm: BioSpectra, Inc.; Status: Ongoing; Reported quantity: 200 kg; Lot: Lot#: TRIS -E04-0226-0016; Exp 2/29/28. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed stability specifications
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BioSpectra, Inc.
- Distributor
- CA
- Lot
- Lot#: TRIS -E04-0226-0016; Exp 2/29/28
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASterile High Performance Ultra Lubricating Eye Drops (Polyethylene Glycol 400, 0.4% Relieves Dry and IrritatedOctober 14, 2026
- FDALidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro PharmaceuticalsOctober 14, 2026
- FDASterile Eye Drops Redness Relief (Glycerin 0.25%, Naphazoline HCl 0.02% Lubricant | Redness Reliever)October 14, 2026
- FDAFosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-DoseOctober 14, 2026
- FDASterile Eye Drops, ORIGINAL, Tetrahydrozoline HCl 0.05% Redness Reliever ¿ Fast Acting Formula) Product size:October 14, 2026
- FDAIMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For IntravenousOctober 14, 2026
Questions about this recall
Was Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25 recalled?
Yes. FDA published recall D-0012-2027 on October 14, 2026. Reported hazard: Failed stability specifications
What should I do if I have this product?
Voluntary: Firm initiated · Telephone